Resolution Chemicals Ltd v H. Lundbeck A/S: SPCs and privity

No items found.
​
April 18, 2013
#
Litigation
#
Life
Table of contents
  • Toc Heading
  • Toc Heading

Darren Smyth’s latest IPKat post concerns the recent decision on a preliminary point in Resolution Chemicals Ltd v H. Lundbeck A/S, and Lundbeck’s SPC for escitalopram.

The case was an action for revocation of Lundbeck’s SPC for invalidity of the underlying patent, and the judgement mainly concerned whether Resolution was estopped from bringing the action by privity of interest with the claimants in an earlier case relating to the same SPC.

Recent Case Reports

See all Case Reports

R.262A applications required to maintain confidentiality in UPC Proceedings
03 March 2026
The Court of Appeal clarified the necessity of formal applications to maintain confidentiality in Unified Patent Court (UPC) proceedings when disclosing ordered information. This ruling arose from a dispute involving patent infringement and confidentiality claims between EOFlow and Insulet.
​
Long arm not available for amended patent
02 March 2026
IMC Créations is a French company specialising in anti-theft systems for vehicles, particularly commercial vehicles. Among other things, it sells locks for the side and rear doors of commercial vehicles. Mul-T-Lock belongs to the Assa Abloy group and specialises in high security locking and access control systems, in particular pick-resistant keys and locks. IMC alleged that Mul-T-Lock’s MPV 1000 padlock infringes its unitary patent EP4153830 and the corresponding Swiss national validation.
​
Re-establishment of rights following failure to apply for a cost decision in time
02 March 2026
The dispute arises out of earlier proceedings between Heraeus Electronics GmbH & Co. KG (claimant) and Vibrantz GmbH (defendant), relating to European Patent No. 3215288. The Munich Local Division issued a substantive decision on 10 October 2025 addressing infringement and a counterclaim for revocation. Among other findings, the court partially revoked the patent in three Contracting Member States and dismissed the infringement action. In its cost decision, the court apportioned 40% of the costs to the defendant and 60% to the claimant.
​